Howard Federoff

Biography

  Howard Federoff, M.D., Ph.D., is the chairman of the scientific advisory board for Ovid Therapeutics. He is also vice chancellor for health affairs and dean of the School of Medicine at the University of California at Irvine, where he has oversight of the clinical, medical educational and research missions. Prior to UCI, Howard was the executive vice president for health sciences at Georgetown University and executive dean of the School of Medicine, where he was a professor of neurology. Prior to Georgetown, he held appointments as senior associate dean; professor of neurology, medicine, microbiology and immunology; professor of oncology and genetics at the University of Rochester School of Medicine; founding director of the Center for Aging and Development Biology at the Aab Institute of Biomedical Sciences; and founding division chief of molecular medicine and gene therapy. His research interests include gene therapy and neurodegenerative diseases. He has published more than 250 peer-reviewed and invited articles and serves as a reviewer for many journals as well as on the editorial board of five journals. Howard served as chair of the NIH Recombinant DNA Advisory Committee from 2007-2010. He chairs the Gene Therapy Resource Program for NHLBI, was president of the American Society for Neural Therapy and Repair from 2013 to 2013 and is president of the American Society for Experimental Neurotherapeutics. Dr. Federoff received his M.S., Ph.D. and M.D. degrees from the Albert Einstein College of Medicine, did his internship, residency and clinical and research fellowships at Massachusetts General Hospital (MGH)/Harvard Medical School, and practiced medicine at MGH, Albert Einstein and Strong Memorial Hospital at the University of Rochester. He is a Fellow of the AAAS and National Academy of Inventors.

Research Interest